Leadership Overview
Abdi İbrahim İlaç has 4 executives leading key functions including strategy, finance, human resources, communications, and sustainability.
Driven by a commitment to public health, Abdi İbrahim İlaç provides essential pharmaceutical services, focusing on innovation and accessibility to maintain and improve people's well-being across Turkey and beyond.
Driven by a commitment to public health, Abdi İbrahim İlaç provides essential pharmaceutical services, focusing on innovation and accessibility to maintain and improve people's well-being across Turkey and beyond.
Leadership Roles at Abdi İbrahim İlaç
Süha Taşpolatoğlu - Chief Executive Officer
Süha Taşpolatoğlu, the Chief Executive Officer at Abdi İbrahim İlaç, directs the overarching strategy and operational execution for the company's pharmaceutical services. This leadership role involves guiding the organization's mission to provide health-beneficial services to the healthcare sector, ensuring alignment with market demands and regulatory standards. The Chief Executive Officer oversees the development and implementation of long-term business objectives, focusing on sustainable growth and market leadership within Turkey's pharmaceutical landscape. Süha Taşpolatoğlu drives innovation in product development and service delivery, ensuring Abdi İbrahim İlaç maintains its position as a key contributor to public health. This executive's purview extends to fostering a culture of excellence and ethical practice throughout the organization, impacting all facets of the company's operations and strategic partnerships. The Chief Executive Officer's decisions directly influence the company's ability to meet evolving healthcare needs and expand its reach.
Mazhar Çavdar - Chief Financial Officer, Country
Mazhar Çavdar, the Chief Financial Officer, Country at Abdi İbrahim İlaç, manages all financial operations and strategic fiscal planning for the Turkish market. This critical position involves overseeing budgeting, forecasting, and financial reporting to ensure the company's fiscal health and profitability. The Chief Financial Officer, Country analyzes market trends and economic conditions to inform investment decisions and optimize resource allocation across various departments. Mazhar Çavdar plays a key role in managing relationships with financial institutions, investors, and regulatory bodies, ensuring compliance with all financial laws and standards. This executive's responsibilities include driving financial efficiency, identifying cost-saving opportunities, and supporting the company's expansion initiatives through robust financial management. By maintaining stringent financial controls, Mazhar Çavdar safeguards the company's assets and supports the strategic goals set forth by the Chief Executive Officer, contributing directly to Abdi İbrahim İlaç's sustained success in the pharmaceutical sector.
Gülçin Oğuz - Chief Financial Officer Asistanı
Gülçin Oğuz, the Chief Financial Officer Asistanı at Abdi İbrahim İlaç, provides essential support to the Chief Financial Officer in managing the company's financial activities. This role involves assisting with financial analysis, data compilation, and the preparation of reports crucial for strategic decision-making. The Chief Financial Officer Asistanı contributes to the monitoring of financial performance, helping to identify variances and support corrective actions. Gülçin Oğuz aids in the coordination of departmental budgets and ensures the accuracy of financial records, facilitating smooth operational workflows. This executive's support is vital for maintaining the integrity of financial data and supporting the financial planning processes. By assisting the Chief Financial Officer, Gülçin Oğuz contributes to the overall financial stability and operational efficiency of Abdi İbrahim İlaç, ensuring that financial operations align with the company's broader business objectives and regulatory requirements.
M. Oğuzcan - President, Human Resources, Communications & Sustainability
M. Oğuzcan, the President, Human Resources, Communications & Sustainability at Abdi İbrahim İlaç, leads critical functions that shape the company's internal culture and external reputation. This executive directs human resources strategies, ensuring the attraction, development, and retention of top talent essential for delivering pharmaceutical services. M. Oğuzcan oversees comprehensive communication strategies, managing internal messaging to foster employee engagement and external relations to enhance brand perception within the healthcare sector. Furthermore, this leadership role encompasses driving sustainability initiatives, aligning the company's operations with environmental and social responsibility goals. M. Oğuzcan champions initiatives that promote ethical business practices and contribute positively to the communities served by Abdi İbrahim İlaç. The President's integrated approach ensures that human capital, corporate messaging, and sustainable practices collectively support the company's mission of maintaining and improving public health.
Explore Leadership Teams in Manufacturing
Moderna is recognized as a pioneer in mRNA medicine, reshaping the way treatments and vaccines are created and delivered. By blending scientific innovation with advanced technology, the company continues to transform how society prevents and addresses disease across infectious conditions, cancer, rare disorders and autoimmune challenges. Guided by a distinctive culture and a global team committed to improving human health, Moderna focuses on developing mRNA-based medicines that can make a meaningful and lasting impact.
Company Leadership
SI
PR

Pfizer is a biopharmaceutical company that researches, develops, manufactures, and markets medicines and vaccines across multiple therapeutic areas. The company focuses on areas such as oncology, internal medicine, inflammation and immunology, and vaccines to help prevent, treat, and manage disease worldwide.
Company Leadership PC
AK
SK
SR
Founded in 1949 and Headquartered in Mumbai, India, Ipca Laboratories Limited (IPCA) is a fully integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
Company Leadership KC
TK
SM
HM
Founded in 1998, Aldevron is a biotechnology privately held company that develops and manufactures plasmid DNA, proteins, enzymes, and antibodies. Aldevron is located in North Dakota.
Company Leadership MC

LG
JM